{
    "id": 10467,
    "fullName": "FANCC mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "FANCC mutant indicates an unspecified mutation in the FANCC gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 2176,
        "geneSymbol": "FANCC",
        "terms": [
            "FANCC",
            "FA3",
            "FAC",
            "FACC"
        ]
    },
    "variant": "mutant",
    "createDate": "08/10/2015",
    "updateDate": "05/15/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7221,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, FANCC mutant pancreatic cancer cells demonstrated increased sensitivity to KU-55933 compared to isogenic FANCC wild-type cell lines in culture (PMID: 17431503).",
            "molecularProfile": {
                "id": 10470,
                "profileName": "FANCC mutant"
            },
            "therapy": {
                "id": 3116,
                "therapyName": "KU-55933",
                "synonyms": null
            },
            "indication": {
                "id": 1793,
                "name": "pancreatic cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6220,
                    "pubMedId": 17431503,
                    "title": "Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17431503"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 13735,
            "approvalStatus": "Guideline",
            "evidenceType": "Risk Factor",
            "efficacyEvidence": "Germline FANCC mutations are associated with increased pancreatic cancer susceptibility (NCCN.org).",
            "molecularProfile": {
                "id": 10470,
                "profileName": "FANCC mutant"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 1793,
                "name": "pancreatic cancer",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10470,
            "profileName": "FANCC mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}